Fibrobiologics Inc (FBLG)

Fibrobiologics Inc. has seen no insider trading activity within the last three months. The most recent recorded transactions occurred in early March 2026, when several executives, including the Chief Executive Officer and Chief Financial Officer, executed multiple share purchases. These historical acquisitions represent the final documented movements by company leadership.
Ticker: FBLG Exchange: NMS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Fibrobiologics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
Khoja Hamid Chief Scientific Officer Officer
Transaction date
Purchase
Price
41.84
Quantity 44,847 -42.9%
Value US$4,231,245
3.7
O'HEERON PETE CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
146.58
Quantity 9,416 -13.0%
Value US$2,535,787
3.7
O'HEERON PETE CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
163.41
Quantity 32,314 +18.5%
Value US$937,577
3.7
O'HEERON PETE CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
0.35
Quantity 17,428 +0.3%
Value US$6,152
0.5
Davis Jason Chief Financial Officer Officer
Transaction date
Purchase
Price
0.41
Quantity 70,000 +inf%
Value US$28,973
1.7
GARCIA RUBEN A General Counsel Officer
Transaction date
Purchase
Price
0.33
Quantity 40,000 +28.6%
Value US$13,056
1.7
GARCIA RUBEN A General Counsel Officer
Transaction date
Purchase
Price
0.34
Quantity 140,000 +inf%
Value US$47,600
2.6
Khoja Hamid Chief Scientific Officer Officer
Transaction date
Purchase
Price
0.84
Quantity 20,000 +177.8%
Value US$16,800
2.6
Khoja Hamid Chief Scientific Officer Officer
Transaction date
Purchase
Price
1.90
Quantity 10,000 +800.0%
Value US$19,000
3.7
O'HEERON PETE Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.91
Quantity 8,500 +0.1%
Value US$16,269
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-05 2026-03-04 B Purchase

Chief Scientific Officer

Officer
44,847 -42.9%
41.84
US$4,231,245
44,847 -42.9% 41.84 US$4,231,245
2026-03-04 2026-03-04 B Purchase

CHIEF EXECUTIVE OFFICER

Executive Director
9,416 -13.0%
146.58
US$2,535,787
9,416 -13.0% 146.58 US$2,535,787
2026-03-04 2026-03-03 B Purchase

CHIEF EXECUTIVE OFFICER

Executive Director
32,314 +18.5%
163.41
US$937,577
32,314 +18.5% 163.41 US$937,577
2026-03-04 2026-03-02 B Purchase

CHIEF EXECUTIVE OFFICER

Executive Director
17,428 +0.3%
0.35
US$6,152
17,428 +0.3% 0.35 US$6,152
2026-03-03 2026-03-02 B Purchase

Chief Financial Officer

Officer
70,000 +inf%
0.41
US$28,973
70,000 +inf% 0.41 US$28,973
2026-03-02 2026-02-27 B Purchase

General Counsel

Officer
40,000 +28.6%
0.33
US$13,056
40,000 +28.6% 0.33 US$13,056
2025-12-12 2025-12-11 B Purchase

General Counsel

Officer
140,000 +inf%
0.34
US$47,600
140,000 +inf% 0.34 US$47,600
2025-05-27 2025-05-27 B Purchase

Chief Scientific Officer

Officer
20,000 +177.8%
0.84
US$16,800
20,000 +177.8% 0.84 US$16,800
2024-08-12 2024-08-12 B Purchase

Chief Scientific Officer

Officer
10,000 +800.0%
1.90
US$19,000
10,000 +800.0% 1.90 US$19,000
2024-08-12 2024-08-12 B Purchase

Chief Executive Officer

Executive Director
8,500 +0.1%
1.91
US$16,269
8,500 +0.1% 1.91 US$16,269